Connor, Clark & Lunn Investment Management Ltd.
Position in RARE — Ultragenyx Pharmaceutical Inc.
CIK 1596800
VANCOUVER, A1
Position in RARE
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$10,494,315
+$4,425,328 QoQ
Shares Held
500,922
+89.8% QoQ
Ownership
0.509%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Connor, Clark & Lunn Investment Management Ltd. holds $703,286,486 across 100 Biotechnology names. RARE ranks #15 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
251,711 | $112,399,029 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
874,089 | $65,635,343 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
836,981 | $52,478,708 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
479,476 | $44,293,992 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32,164 | $24,851,192 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
134,792 | $22,782,543 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
1,019,951 | $22,194,133 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
384,681 | $20,280,382 |
All Filings in RARE
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,494,315 | 500,922 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $6,068,987 | 263,869 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,373,973 | 78,922 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $213,978 | 5,885 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,625,865 | 44,901 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,136,563 | 27,016 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,180,970 | 75,265 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $6,694,820 | 162,891 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $7,261,462 | 155,525 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $4,134,373 | 86,457 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $6,496,677 | 182,235 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $9,504,210 | 206,031 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $8,335,105 | 207,858 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $10,664,888 | 230,194 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $7,802,513 | 188,421 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,943,782 | 32,581 | Shares | Sole | 2022-08-05 | |
| 2021-06-30 | $224,739 | 2,357 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,760,958 | 15,466 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $363,517 | 2,626 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||